Duearity AB Cash Flow Conversion Efficiency

Latest as of June 2024: 0.036x

Duearity AB cash flow conversion efficiency. Based on the latest financial reports, Duearity AB (DEAR) has a cash flow conversion efficiency ratio of 0.036x as of June 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-416.00K ≈ $-44.77K USD) by net assets (Skr-11.54 Million ≈ $-1.24 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Duearity AB (2020–2023)

Cash flow conversion efficiency of Duearity AB from 2020 to 2023. This chart illustrates how Duearity AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. View current stock price of Duearity AB for real-time trading data and today's change.

Duearity AB Cash Flow Conversion Ratio Explained

Duearity AB cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Duearity AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Duearity AB ranked by their cash flow conversion efficiency. Also see Duearity AB market capitalisation for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Eden Research plc
LSE:EDEN
-0.048x
Krakchemia SA
WAR:KCH
0.004x
PUNCH PUNK S.A. ZY-10
F:6K7
N/A
Southstone Minerals Ltd
V:SML
-0.898x
Tortilla Mexican Grill PLC
LSE:MEX
-0.810x
Challenger Energy Group PLC
LSE:CEG
-0.008x
Blaize Holdings, Inc. Warrants
NASDAQ:BZAIW
-0.507x
Profusa, Inc. Common Stock
NASDAQ:PFSA
0.091x

Annual Cash Flow Conversion Efficiency for Duearity AB (2020–2023)

The table below shows the annual cash flow conversion efficiency of Duearity AB from 2020 to 2023. Review Duearity AB financial flexibility index to assess the company's free cash flow relative to its total liabilities.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2023-12-31 Skr-2.39 Million
≈ $-256.77K
Skr-24.36 Million
≈ $-2.62 Million
10.207x +404.16%
2022-12-31 Skr6.06 Million
≈ $652.48K
Skr-20.35 Million
≈ $-2.19 Million
-3.356x -174.66%
2021-12-31 Skr11.04 Million
≈ $1.19 Million
Skr-13.49 Million
≈ $-1.45 Million
-1.222x -331.51%
2020-12-31 Skr3.79 Million
≈ $408.19K
Skr-1.07 Million
≈ $-115.58K
-0.283x --

About Duearity AB

ST:DEAR Sweden Medical Devices
Market Cap
$331.97K
Skr3.08 Million SEK
Market Cap Rank
#31220 Global
#732 in Sweden
Share Price
Skr0.02
Change (1 day)
+0.00%
52-Week Range
Skr0.02 - Skr0.02
All Time High
Skr25.05
About

Duearity AB (publ), a medical technology company, engages in the development and production of solutions for tinnitus. The company offers Tinearity G1, a medical device for people suffering from tinnitus that transmits white noise using bone conduction technology non-invasively to the inner ear in order to treat and relieve symptoms; and Tinearity-AI, which uses artificial intelligence to help pe… Read more